ARCHIVES

No Cancer Letter For Two Weeks

This article is from The Cancer Letter archive.

Vol. 16 No. 32 | August 10, 1990

Download PDF Visit The Full Archive

Related Articles

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

April 24, 2009

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

Spending Measures Include Provisions On Ethics For NIH Extramural Scientists.

July 11, 2008

Lasker Awards Resume; ASCO Fall Conference Scheduled For October

September 21, 1990

Solomon Garb’s Questions/Answers

January 9, 1981

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994